TickerFacts.

Zivo Bioscience, Inc. (ZIVO): Operating Income

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$13.36M
Year ended 2024-12-31
-$8.46M
Trailing 12 months to 2025-09-30
2010-12-31: -$4.06M2011-12-31: -$1.94M2012-12-31: -$2.08M2013-12-31: -$3.11M2014-12-31: -$5.15M2015-12-31: -$3.06M2016-12-31: -$3.49M2017-12-31: -$6.33M2018-12-31: -$6.13M2019-12-31: -$8.35M2020-12-31: -$8.56M2021-12-31: -$8.65M2022-12-31: -$8.73M2023-12-31: -$7.26M2024-12-31: -$13.36M-$13.36M
2010-12-31 Operating Income (USD) 2024-12-31
Period endedOperating IncomeChange YoYSource filing
2024-12-31-$13.36Mn/m2025-03-18, From 2024-01-01
2023-12-31-$7.26Mn/m2025-03-18, From 2023-01-01
2022-12-31-$8.73Mn/m2024-03-15, From 2022-01-01
2021-12-31-$8.65Mn/c2023-03-14, From 2021-01-01
2020-12-31-$8.56Mn/m2022-04-22, From 2020-01-01
2019-12-31-$8.35Mn/m2021-02-25, From 2019-01-01
2018-12-31-$6.13Mn/m2020-03-26, From 2018-01-01
2017-12-31-$6.33Mn/m2019-02-12, From 2017-01-01
2016-12-31-$3.49Mn/m2018-02-21, From 2016-01-01
2015-12-31-$3.06Mn/m2017-03-31, From 2015-01-02
2014-12-31-$5.15Mn/m2016-03-29, From 2014-01-02
2013-12-31-$3.11Mn/m2015-04-06, From 2013-01-02
2012-12-31-$2.08Mn/m2014-03-31, From 2012-01-02
2011-12-31-$1.94Mn/m2013-03-25, From 2011-01-01
2010-12-31-$4.06Mn/a2012-03-30, From 2010-01-02